Sung Ji Nam analyst

Currently out of the existing stock ratings of Sung Ji Nam, 140 are a BUY (91.5%), 13 are a HOLD (8.5%).

Sung Ji Nam

Work Performance Price Targets & Ratings Chart

Analyst Sung Ji Nam, carries an average stock price target met ratio of 59.11% that have a potential upside of 28.67% achieved within 284 days. Previously, Sung Ji Nam worked at BTIG, CANTOR FITZGERALD, AVONDALE.

Sung Ji Nam’s has documented 320 price targets and ratings displayed on 30 stocks. The coverage was on Healthcare, Consumer Cyclical sectors.

Most recent stock forecast was given on CSTL, Castle Biosciences at 04-Nov-2025.

Wall Street Analyst Sung Ji Nam

Analyst best performing recommendations are on GNMK (GENMARK DIAGNOSTICS).
The best stock recommendation documented was for VCYT (VERACYTE) at 11/4/2020. The price target of $42 was fulfilled within 1 day with a profit of $1.97 (4.92%) receiving and performance score of 49.21.

Average potential price target upside

BDSX Biodesix BNGO Bionano Genomics CDNA Caredx CSTL Castle Biosciences FLDM Fluidigm FLGT Fulgent Genetics GTH Genetron Holdings Ltd ILMN Illumina LMNX Luminex TMO Thermo Fisher Scientific VCYT Veracyte BRKR Bruker DMTK DermTech QTRX Quanterix Corp OLK Olink Holding AB ADR TKNO Alpha Teknova ADPT Adaptive Biotechnologies Corp CNTG Centogene B V GH Guardant Health MYGN Myriad Genetics PACB Pacific Biosciences of California TWST Twist Bioscience Corp QTNT Quotient Ltd TECH Bio-Techne Corp WAT Waters LAB Standard Biotools GNMK GenMark Diagnostics DHR Danaher EXAS EXACT Sciences GT Goodyear Tire & Rubber Co

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 11-Aug-2021

$35

$7.28 (26.26%)

$27

1 months 25 days ago
(10-Aug-2026)

6/10 (60%)

$10.14 (40.79%)

208

Buy Since 15-Jun-2026

$27

$-0.72 (-2.60%)

$26

1 months 29 days ago
(06-Aug-2026)

2/2 (100%)

$4.9 (22.17%)

43

Buy Since 23-Nov-2020

$32

$4.28 (15.44%)

3 months 10 days ago
(25-Jun-2026)

2/5 (40%)

$11.96 (59.68%)

44

Buy Since 23-Nov-2020

$40

$12.28 (44.30%)

$60

1 years 4 months 14 days ago
(21-May-2025)

1/5 (20%)

$32.1 (406.33%)

49

Hold Since 18-Nov-2021

4 years 4 months 23 days ago
(12-May-2022)

1/2 (50%)

$47.4 (10.47%)

38

Show more analysts

Please expand the browser size to see the chart

✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?